<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-08T04:19:59Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/92186" metadataPrefix="rdf">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/92186</identifier><datestamp>2024-01-11T02:43:42Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:docta.ucm.es:20.500.14352/92186">
      <dc:title>IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis</dc:title>
      <dc:creator>Valle Noguera, Ana</dc:creator>
      <dc:creator>Sancho Temiño, Lucía</dc:creator>
      <dc:creator>Castillo González, Raquel</dc:creator>
      <dc:creator>Villa Gómez, Cristina</dc:creator>
      <dc:creator>Gomez Sánchez, María José</dc:creator>
      <dc:creator>Ochoa Ramos, Anne</dc:creator>
      <dc:creator>González Granado, José María</dc:creator>
      <dc:creator>Cruz Adalia, Aranzazu</dc:creator>
      <dc:description>Group 3 innate lymphoid cells (ILC3s) are vital for defending tissue barriers from invading pathogens. Hypoxia influences the production of intestinal ILC3-derived cytokines by activating HIF. Yet, the mechanisms gov- erning HIF-1a in ILC3s and other innate RORgt+ cells during in vivo infections are poorly understood. In our study, transgenic mice with specific Hif-1a gene inactivation in innate RORgt+ cells (RAG1KO HIF- 1a6Rorc) exhibit more severe colitis following Citrobacter rodentium infection, primarily due to the inability to upregulate IL-22. We find that HIF-1a6Rorc mice have impaired IL-22 production in ILC3s, while non- ILC3 innate RORgt+ cells, also capable of producing IL-22, remain unaffected. Furthermore, we show that IL-18, induced by Toll-like receptor 2, selectively triggers IL-22 in ILC3s by transcriptionally upregulating HIF-1a, revealing an oxygen-independent regulatory pathway. Our results highlight that, during late-stage C. rodentium infection, IL-18 induction in the colon promotes IL-22 through HIF-1a in ILC3s, which is crucial for protection against this pathogen.</dc:description>
      <dc:date>2024-01-10T09:52:46Z</dc:date>
      <dc:date>2024-01-10T09:52:46Z</dc:date>
      <dc:date>2023-12-26</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Valle-Noguera A, Sancho-Temiño L, Castillo-González R, Villa-Gómez C, Gomez-Sánchez MJ, Ochoa-Ramos A, Yagüe-Fernández P, Soler Palacios B, Zorita V, Raposo-Ponce B, González-Granado JM, Aragonés J, Cruz-Adalia A. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis. Cell Rep. 2023 Dec 26;42(12):113508. doi: 10.1016/j.celrep.2023.113508. Epub 2023 Nov 28. PMID: 38019650.</dc:identifier>
      <dc:identifier>2211-1247</dc:identifier>
      <dc:identifier>10.1016/j.celrep.2023.113508</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.14352/92186</dc:identifier>
      <dc:identifier>https://www.sciencedirect.com/journal/cell-reports</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-093647-B-I00/ES/CONTROL DE LA REGULACION METABOLICA Y MOLECULAR MEDIADA POR HIF-1A EN LAS CELULAS INNATAS LINFOIDES/</dc:relation>
      <dc:relation>PID2021-122780OB-I00</dc:relation>
      <dc:relation>CNS2022-135365</dc:relation>
      <dc:relation>info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00306/ES/INMUNOLOGIA, INMUNOPATOLOGIA Y TERAPIA EN ENFERMEDAD INFLAMATORIA INTESTINAL/</dc:relation>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
      <dc:publisher>Cell Press</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>